AMPLION INC.
BEND, OR · Founded 2014 · CIK 0001628740 · Biotech · Acquired
BiomarkerBase, an AI-powered biomarker database and analysis platform that identifies actionable precision medicine opportunities by examining biomedical literature and clinical data to match drugs wi
amplion.com →- Grants
- $300K
- 2 awards
- Sector median: 1
- Raised
- $1.0M
- 1 Form D · Jan 2015
- 141 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20142015201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,017,182 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Development of Deep Learning Models for Biomarker Identification and Classification | $150,000 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Development of Deep Learning Models for Biomarker Identification and Classification | $150,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2569 | SENEX BIOTECHNOLOGY, INC. | — | $1.0M |
| 2570 | Decoy Therapeutics, Inc. | — | $1.0M |
| 2571 | NEW HORIZON BIOTECH INC | — | — |
| 2572 | AMPLION INC. | — | $1.0M |
| 2573 | Biosceptre International Ltd | — | $1.0M |
| 2574 | MATINAS BIOPHARMA, INC. | — | $1.0M |
| 2575 | CURIS INC | — | $964K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Jean-Paul AudetteDirector · Executive Officer · Promoter
- Adam CarrollDirector · Executive Officer · Promoter
- Christopher KraybillDirector
- J. SchmidDirector
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.